about
Mitochondrial biogenesis in health and disease. Molecular and therapeutic approachesInhibition of xanthine oxidase by allopurinol prevents skeletal muscle atrophy: role of p38 MAPKinase and E3 ubiquitin ligasesTelmisartan as metabolic modulator: a new perspective in sports doping?PTK2 rs7460 and rs7843014 polymorphisms and exceptional longevity: a functional replication study.Serum irisin levels, precocious myocardial infarction, and healthy exceptional longevity.Exercise acts as a drug; the pharmacological benefits of exerciseThe p38-PGC-1α-irisin-betatrophin axis: Exploring new pathways in insulin resistance.Epigenetic biomarkers: A new perspective in laboratory diagnostics.Sestrins: novel antioxidant and AMPK-modulating functions regulated by exercise?Pharmacological properties of physical exercise in the elderly.Erythropoietin and the heart: physiological effects and the therapeutic perspective.How does the journal impact factor affect the CV of PhD students?New molecular targets and lifestyle interventions to delay aging sarcopenia.Effects of allopurinol on exercise-induced muscle damage: new therapeutic approaches?The ApoE gene is related with exceptional longevity: a systematic review and meta-analysis.Protective effect of trehalose-loaded liposomes against UVB-induced photodamage in human keratinocytes.Age associated low mitochondrial biogenesis may be explained by lack of response of PGC-1α to exercise training.Erythropoietin and myocardial infarction.Vitamin C supplementation does not improve hypoxia-induced erythropoiesis.Can enhanced autophagy be associated with human longevity? Serum levels of the autophagy biomarker beclin-1 are increased in healthy centenarians.Living at high altitude in combination with sea-level sprint training increases hematological parameters but does not improve performance in rats.Intermittent hypobaric hypoxia applicability in myocardial infarction prevention and recovery.Ex vivo erythrocyte generation and blood doping.Desmopresssin and hemodilution: implications in doping.Cycling: to race or to live - reflections on skewed priorities?Altitude exposure in sports: the Athlete Biological Passport standpoint.Effects of acute exercise and allopurinol administration on soluble urokinase plasminogen activator receptor (suPAR).Elite athletes live longer than the general population: a meta-analysis.Improvement in sprint performance: doping or nature?Effects of acute exercise and xanthine oxidase inhibition on novel cardiovascular biomarkers.Exercise as an adjuvant intervention in opiate dependence.PPARgamma agonist pioglitazone does not enhance performance in mice.Influence of training and a maximal exercise test in analytical variability of muscular, hepatic, and cardiovascular biochemical variables.Increased average longevity among the "Tour de France" cyclists.Anemia, heart failure and exercise training.An 18-minute submaximal exercise test to assess cardiac fitness in response to aerobic training.Impact of exercise training on neuroplasticity-related growth factors in adolescents.Autism spectrum disorders: possible implications of BDNF modulation through epigenetics.Influence of middle-distance running on muscular micro RNAs.Effect of exhaustive running exercise on red blood cell distribution width.
P50
Q28235551-9E94AE41-F28F-4191-920A-ED8AB809A0C0Q28389456-06F97156-D269-4813-AC0F-6D6532D39D8AQ34237147-A13413C8-BD67-4987-9D6E-C2BBA5EF31ADQ34370851-AE1B8948-CDF6-4ADA-9918-98563E82712BQ34419502-82CACBCB-2D9F-4A6C-9CAD-0134BF71AD72Q36252826-A7EE3151-72F3-488D-B4FF-AC6FA53A5EA1Q37568271-3F78EB0F-71D0-43FE-B5D1-99D92DAD883BQ38015975-0ABB6C97-8D5F-4095-8CD7-CD58915C7055Q38077486-035EDC26-796C-476D-B243-0359B358380FQ38147443-E729151D-40DD-4C7C-A942-C2BAF4EFA3DDQ38174673-B913E1DF-DE6E-41D2-A2E4-AF6EDF1F4ECAQ38182825-CAB6FC79-3893-443A-94B6-7B27B15BA0C9Q38234905-74DA0220-B66C-4BFA-A58E-F340429042E0Q38245545-C8AB7544-E7D4-4085-B880-C0DE06DFDA23Q38266787-B90201A4-C360-4390-A159-573EB5B4708FQ38972491-4AF87714-5CFF-4D9B-985E-3B55FFF871F5Q42137713-713429B7-4D0C-4206-8F05-4637131302B3Q42348107-23C13A18-D736-43AD-B558-61D80FDDCBC2Q42460276-5CCDEFEB-95B6-467B-9879-7B48BF146725Q42467004-14DF9B74-1675-495A-B4F2-27098D4A1FBDQ42789284-4BAFA0E5-4BFD-41B4-84C5-BD2219075405Q43193972-021A7CFC-6D4F-48CC-8ED5-52B1626D68E3Q43195888-128EBE57-6FDD-4888-93D8-877DF7F6A88FQ43249730-FFF95F9D-7528-4925-90E4-E605E9E27CE0Q43704185-E770C3E4-26E9-4453-B1F3-6D5CC456105BQ43840740-2C221ED8-C8D4-4D61-9358-F6080EA68CD5Q43921009-0BD36C73-9D74-41E4-AEF6-46F5D9D05105Q43984121-1BEE5F4F-7390-45B8-BDD9-4F18CA401459Q44065251-E2A2F93E-A90C-49BE-89EA-55CEE262C8AAQ44497204-726C5ACD-3837-44F4-A7D0-19D91A0CEDC8Q44993532-AD1CEA2B-84FD-4747-81AE-4E58E10E780DQ44994548-DB35319C-B2F0-4E3A-A172-74C8E2C1454AQ45330193-48E699E6-FD2B-40C8-B682-89AE4C6105BBQ45382840-F466E753-E575-4190-9870-3556A8CBB5CEQ46974068-96248C9B-B997-4D5E-AA59-53D1944C3D7AQ47584338-17AAF92F-5166-43A8-8991-BA08B36CEEADQ47672579-39B5DAE3-F311-45C8-8032-EBDFBA83301DQ48204264-667594A1-637C-4573-BC65-AC154CC21522Q48258655-F843D10E-4110-4A9A-AD96-E8949DFD66A5Q50461917-E3CFADE1-1494-46B9-A474-DC102E498260
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Fabian Sanchis-Gomar
@ast
Fabian Sanchis-Gomar
@en
Fabian Sanchis-Gomar
@es
Fabian Sanchis-Gomar
@nl
Fabian Sanchis-Gomar
@sl
type
label
Fabian Sanchis-Gomar
@ast
Fabian Sanchis-Gomar
@en
Fabian Sanchis-Gomar
@es
Fabian Sanchis-Gomar
@nl
Fabian Sanchis-Gomar
@sl
prefLabel
Fabian Sanchis-Gomar
@ast
Fabian Sanchis-Gomar
@en
Fabian Sanchis-Gomar
@es
Fabian Sanchis-Gomar
@nl
Fabian Sanchis-Gomar
@sl
P106
P1153
35103550200
P21
P31
P496
0000-0003-0424-4208